Company: CERO
Filing Date: 2025-08-22
Form Type: 424B3
Source: 0001213900-25-080017
Chunk: 9

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-08-22
Form: 424B3
Chunk 9
---
 share, of Legacy CERo.

“ Legacy CERo warrants” refers to the warrants to purchase shares of Legacy CERo preferred stock.

<div align='center'>vi</div>

“ Merger Sub” refers to PBCE Merger Sub, Inc., a Delaware corporation.

“ Nasdaq” refers to the Nasdaq Stock Market LLC.

“ New Keystone Purchase Agreement” refers to the Common Stock Purchase Agreement, dated as of July 11, 2025, by and between CERo and Keystone.

“ November 2024 Keystone Purchase Agreement” refers to the Common Stock Purchase Agreement, dated as of November 8, 2024, by and between CERo and Keystone.

“ PBAX”refers to Phoenix Biotech Acquisition Corp., a Delaware corporation.

“ PIPE Financings” refers to the First PIPE Financing, the Second PIPE Financing, the Third PIPE Financing and the Fourth PIPE Financing.

“ PIPE Registration Rights Agreement” refers to the First PIPE Registration Rights Agreement, the Second PIPE Registration Rights Agreement, the Third PIPE Registration Rights Agreement and the Fourth PIPE Registration Rights Agreement.

“ Preferred Stock” refers to the shares of Series A, Series B, Series C, and Series D Preferred Stock, par value $0.0001 per share, of CERo.

“ Preferred Shares” refer to the shares of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock issued in the PIPE Financings, including the Warrant Preferred Shares.

“ Preferred Warrants” refer to warrants to purchase shares of Series A Preferred Stock.

“ Primary Earnout Shares” refer to the 600 shares of Common Stock issued to the holders of Legacy CERo common stock and Legacy CERo preferred stock in connection with the Business Combination, 500 of which are subject to vesting upon the achievement of certain stock price-based earnout targets and 100 of which are subject to vesting upon a change of control, respectively.

“ Private Placement Warrants” refer to private placement warrants to purchase shares of Common Stock, at an exercise price of $23,000.00 per share, that were originally sold in a private placement concurrently with the Initial Public Offering.

“ Public Warrants” refer to the warrants to purchase shares of Common Stock, at an exercise price of $23,000.00 per share, that were originally issued in the Initial Public Offering.

“ Reverse Stock Splits” refers to the Company’s reverse stock split that became effective at 12:01 a.m.